Compare AEON & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEON | ADIL |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 7.8M |
| IPO Year | N/A | 2018 |
| Metric | AEON | ADIL |
|---|---|---|
| Price | $0.67 | $0.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $7.20 | $1.50 |
| AVG Volume (30 Days) | 240.9K | ★ 356.0K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.38 | $0.22 |
| 52 Week High | $64.80 | $1.30 |
| Indicator | AEON | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 31.98 | 43.30 |
| Support Level | $0.78 | $0.30 |
| Resistance Level | $0.83 | $0.33 |
| Average True Range (ATR) | 0.09 | 0.02 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 4.35 | 54.70 |
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.